Novel biomarkers of mitochondrial dysfunction in Long COVID patients
GeroScience · 04.11.2024 · 47 (2) · 2245-2261
DOI: 10.1007/s11357-024-01398-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift GeroScience, online erschienen am 04.11.2024. Verfasst von Titanilla Szögi und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary. Hauptthemen laut MEDLINE: COVID-19, Mitochondria, Mitochondrial Diseases. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nemzeti Kutatási Fejlesztési és Innovációs Hivatal, Horizon 2020 Framework Programme, Nemzeti Kutatási, Fejlesztési és Innovaciós Alap.
Abstract (Originalsprache)
Coronavirus disease 2019 (COVID-19) can lead to severe acute respiratory syndrome, and while most individuals recover within weeks, approximately 30–40% experience persistent symptoms collectively known as Long COVID, post-COVID-19 syndrome, or post-acute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (PASC). These enduring symptoms, including fatigue, respiratory difficulties, body pain, short-term memory loss, concentration issues, and sleep disturbances, can persist for months. According to recent studies, SARS-CoV-2 infection causes prolonged disruptions in mitochondrial function, significantly altering cellular energy metabolism. Our research employed transmission electron microscopy to reveal distinct mitochondrial structural abnormalities in Long COVID patients, notably including significant swelling, disrupted cristae, and an overall irregular morphology, which collectively indicates severe mitochondrial distress. We noted increased levels of superoxide dismutase 1 which signals oxidative stress and elevated autophagy-related 4B cysteine peptidase levels, indicating disruptions in mitophagy. Importantly, our analysis also identified reduced levels of circulating cell-free mitochondrial DNA (ccf-mtDNA) in these patients, serving as a novel biomarker for the condition. These findings underscore the crucial role of persistent mitochondrial dysfunction in the pathogenesis of Long COVID. Further exploration of the cellular and molecular mechanisms underlying post-viral mitochondrial dysfunction is critical, particularly to understand the roles of autoimmune reactions and the reactivation of latent viruses in perpetuating these conditions. This comprehensive understanding could pave the way for targeted therapeutic interventions designed to alleviate the chronic impacts of Long COVID. By utilizing circulating ccf-mtDNA and other novel mitochondrial biomarkers, we can enhance our diagnostic capabilities and improve the management of this complex syndrome.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.
- Competence Centre of the Life Sciences Cluster of the Centre of Excellence for Interdisciplinary Research, Development and Innovation, University of Szeged, Szeged, Hungary.
- Department of Oto-Rhino- Laryngology and Head-Neck Surgery, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.
- Department of Pediatrics and Pediatric Health Center, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.
- Pulmonology Clinic, Albert Szent-Györgyi Medical and Pharmaceutical Centre, University of Szeged, Szeged, Hungary.
- Department of Internal Medicine, Albert Szent-Györgyi Medical School, University of Szeged, Szeged, Hungary.
ORCID-Profile: Tibor Pankotai
Förderung
- Nemzeti Kutatási Fejlesztési és Innovációs Hivatal
- Horizon 2020 Framework Programme
- Nemzeti Kutatási, Fejlesztési és Innovaciós Alap
- Magyar Tudományos Akadémia
- University of Szeged
Zitieren
APA
Szögi, T., Borsos, B. N., Masic, D., Radics, B., Bella, Z., Bánfi, A., Ördög, N., Zsiros, C., Kiricsi, Á., Pankotai-Bodó, G., Kovács, Á., Paróczai, D., Botkáné, A. L., Kajtár, B., Sükösd, F., Lehoczki, A., Polgár, T., Letoha, A., Pankotai, T., & Tiszlavicz, L. (2024). Novel biomarkers of mitochondrial dysfunction in Long COVID patients. GeroScience, 47(2), 2245-2261. https://doi.org/10.1007/s11357-024-01398-4
Vancouver
Szögi T, Borsos BN, Masic D, Radics B, Bella Z, Bánfi A, et al. Novel biomarkers of mitochondrial dysfunction in Long COVID patients. GeroScience. 2024;47(2):2245-2261. doi:10.1007/s11357-024-01398-4
BibTeX
@article{Szgi2024,
author = {Szögi, Titanilla and Borsos, Barbara N and Masic, Dejana and Radics, Bence and Bella, Zsolt and Bánfi, Andrea and Ördög, Nóra and Zsiros, Csenge and Kiricsi, Ágnes and Pankotai-Bodó, Gabriella and Kovács, Ágnes and Paróczai, Dóra and Botkáné, Andrea Lugosi and Kajtár, Béla and Sükösd, Farkas and Lehoczki, Andrea and Polgár, Tamás and Letoha, Annamária and Pankotai, Tibor and Tiszlavicz, László},
title = {Novel biomarkers of mitochondrial dysfunction in Long COVID patients},
journal = {GeroScience},
year = {2024},
volume = {47},
number = {2},
pages = {2245--2261},
doi = {10.1007/s11357-024-01398-4}
}
EUVIMED